Johnson & Johnson (JNJ): New Drugs and Better Manufacturing Make This Stock a Buy

Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries. The company maintains a diverse revenue base, a robust...

Keep Reading →